Skip to NavigationSkip to content

News

Eli Lilly Shanghai, an affiliate of the wider company, has enlisted the help of biopharma firm Hutchinson China MediTech, or Chi-Med, to...
Biopharma firm AI Therapeutics is partnering with Yale School of Medicine to launch a new clinical trial to identify the efficacy of a drug...
AstraZeneca has teased new data from a Phase 3 study of its sodium-glucose co-transporter-2 (SGLT2) inhibitor Farxiga (dapagliflozin) in the...
The EMA's Committee for Medicinal Products for Human Use (CHMP) has given its backing to Kyowa Kirin’s Crysvita (burosumab) to be used in the...
The subcutaneous (SC) formulation of Remsima, Celltrion’s biosimilar version of infliximab, has secured approval from the European Commission...
AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062 in the treatment of non-...
Moderna has revealed a second investment of $472 million from the US Government’s Biomedical Advanced Research and Development Authority (BARDA...
Biocon was hit with bad news over the weekend as the National Task Force for COVID-19 in its home country of India decided not to back its anti-...
The FDA has awarded approval to Kite's Tecartus, the company’s second approved CAR T cell therapy after Yescarta, and the first authorised for the...
AstraZeneca has secured two new recommendations for approval of its products from the European Medicines Agency’s Committee for Medicinal Products...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches